FDA Grants Breakthrough Device Designation for Dexcom Hospital CGM System
Dexcom CGM to be evaluated for performance in the hospital and for the potential of more effective glycemic management and improved patient outcomes in the hospital settingBreakthrough Device Designation from the FDA is a critical milestone for in-patient Dexcom CGM useThis designation provides a more efficient and...
Source: pharmiweb.com